五洲医疗跌0.37%，成交额3790.29万元，近5日主力净流入42.04万

Core Viewpoint - Wuzhou Medical's stock experienced a slight decline of 0.37% on February 2, with a total market capitalization of 2.71 billion yuan and a trading volume of 37.90 million yuan [1] Business Overview - The company specializes in the research, production, and sales of disposable sterile infusion medical devices, including various types of syringes, infusion sets, blood transfusion sets, and other related medical supplies [2] - Wuzhou Medical has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, indicating its strong market position and innovation capabilities [2] Financial Performance - As of the 2024 annual report, overseas revenue accounted for 96.88% of total revenue, benefiting from the depreciation of the Renminbi [3] - For the period from January to September 2025, Wuzhou Medical achieved a revenue of 345 million yuan, representing a year-on-year growth of 0.82%, while net profit attributable to shareholders decreased by 46.09% to 18.51 million yuan [7] Shareholder and Market Activity - As of January 20, the number of shareholders decreased by 2.28% to 5,364, with an average of 7,488 circulating shares per person, which increased by 2.33% [7] - The company has distributed a total of 81.60 million yuan in dividends since its A-share listing [8] - Notably, as of September 30, 2025, the fund "Noan Multi-Strategy Mixed A" exited the list of the top ten circulating shareholders [9]